Key facts
- This page summarizes Daniel Lochner's Form 4 filing for Tectonic Therapeutic, Inc. (TECX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 06 Feb 2025, 16:05.
Daniel Lochner - 04 Feb 2025 Form 4 Insider Report for Tectonic Therapeutic, Inc. (TECX)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- TECX
- Reported as of
- 04 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Feb 2025, 16:05:12 UTC
- Prior SEC filing
- 24 Jun 2024
- Next SEC filing
- 07 Feb 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel Lochner
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Daniel Lochner filed Form 4 for Tectonic Therapeutic, Inc. (TECX) on 06 Feb 2025.
Change
- Previous filing in this sequence was filed on 24 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TECX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +18,074
- Change %
- Price
- $0.000000
- Shares after
- 18,074
- Date
- 04 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TECX
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +32,862
- Change %
- Price
- $0.000000
- Shares after
- 32,862
- Date
- 04 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 32,862
- Exercise price
- $48.01
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 3 equal annual installments on each of February 4, 2026, February 4, 2027 and February 4, 2028, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
Footnote F2
The shares subject to the option vest in 48 equal monthly installments beginning on March 4, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date.